LianBio
USD0.32
-0.03 (-8.28%)
CEO
Adam Leo Stone
IPO Date
2021-11-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.31
Prev. Close
$0.35
Day Low
$0.28
Day High
$0.35
52W Low
$0.28
52W High
$0.35
Market Cap
$0.03B
Volume
2.48M
| 19,218 |
| $4.76 |
| 20 Feb 2024 | Poukalov Konstantin | director | M-Exempt | Disposed | 36,300 | $2.52 |
| 20 Feb 2024 | Stone Adam Leo | director, officer: Interim CEO | M-Exempt | Acquired | 36,300 | $2.52 |
| 20 Feb 2024 | Stone Adam Leo | director, officer: Interim CEO | F-InKind | Disposed | 19,218 | $4.76 |
| 20 Feb 2024 | Stone Adam Leo | director, officer: Interim CEO | M-Exempt | Disposed | 36,300 | $2.52 |
| 20 Feb 2024 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | M-Exempt | Acquired | 36,300 | $2.52 |
| 20 Feb 2024 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | F-InKind | Disposed | 19,218 | $4.76 |
| 20 Feb 2024 | PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | M-Exempt | Disposed | 36,300 | $2.52 |
| 20 Feb 2024 | GIANAKAKOS ANASTASIOS | director | M-Exempt | Acquired | 36,300 | $2.52 |